Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-15-202661
Filing Date
2015-05-28
Accepted
2015-05-28 06:06:53
Documents
5
Period of Report
2015-05-27

Document Format Files

Seq Description Document Type Size
1 6-K d934478d6k.htm 6-K 10338
2 EX-99.1 d934478dex991.htm EX-99.1 159691
3 GRAPHIC g934478dsp005a.jpg GRAPHIC 42153
4 GRAPHIC g934478dsp005b.jpg GRAPHIC 14075
5 GRAPHIC g934478dsp014.jpg GRAPHIC 14313
  Complete submission text file 0001193125-15-202661.txt   268623
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 15893837
SIC: 2834 Pharmaceutical Preparations